Skip to main content
. 2018 Jun 27;9:2500. doi: 10.1038/s41467-018-04664-0

Fig. 5.

Fig. 5

SREBP-1 protects vemurafenib-resistant cells from lipid peroxidation. BRAFV600E-mutant PDX tumors (mel6 model) were transplanted into nude mice (NMRI-Fox1nu) which were blindly administered vehicle (n = 8), fatostatin (20 mg/kg) (n = 10), vemurafenib (20 mg/kg) (n = 10) or a combination of vemurafenib and fatostatin (n = 10) (daily by oral gavage). a Tumor size was measured blindly with digital calipers every 3 days. The tumor pictures in (b) show the tumors that represent the median of their respective cohort. c Expression of Ki67 protein in PDX tumors that represent the median of their respective cohort. Scale bars indicate 100 μm. d Lipidomics of PDX tumor homogenate. e MDA quantification of PDX tumor homogenate. The data represent the average over all mice for each cohort compared to the control. Data are represented as mean ± s.e.m. (**p < 0.01)